Studying at the University of Verona
Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.
Study Plan
This information is intended exclusively for future freshmen who will enroll for the 2026/2027 academic year.If you are already enrolled in this course of study, consult the information available on the course page:
Combined Bachelor's + Master's degree in Pharmacy - Enrollment until 2025/2026The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.
1° Year
| Modules | Credits | TAF | SSD |
|---|
2° Year It will be activated in the A.Y. 2027/2028
| Modules | Credits | TAF | SSD |
|---|
3° Year It will be activated in the A.Y. 2028/2029
| Modules | Credits | TAF | SSD |
|---|
4° Year It will be activated in the A.Y. 2029/2030
| Modules | Credits | TAF | SSD |
|---|
5° Year It will be activated in the A.Y. 2030/2031
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
Legend | Type of training activity (TTA)
TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.
Biotechnological Pharmaceuticals (It will be activated in the A.Y. 2030/2031)
Teaching code
4S011758
Credits
6
Scientific Disciplinary Sector (SSD)
BIOS-11/A - Farmacologia
Learning objectives
The course aims to teach the student the knowledge relating to biotechnological products for therapeutic use: proteins, nucleotides, monoclonal antibodies, cell therapies, gene and cell therapy. Knowledge will be provided relating to:
different types, extraction, purification and synthesis processes.
differences in terms of pharmacokinetics and pharmacodynamics from drugs based on low molecular weight molecules
uses and therapeutic indications
clinical advantages and limitations
health aspects.